The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001164508.2(NEB):c.6076-1G>T

CA348802582

553493 (ClinVar)

Gene: NEB
Condition: nemaline myopathy
Inheritance Mode: Autosomal recessive inheritance
UUID: c0faa268-cef1-4338-9232-2cc5e99b2022
Approved on: 2024-08-07
Published on: 2024-10-01

HGVS expressions

NM_001164508.2:c.6076-1G>T
NM_001164508.2(NEB):c.6076-1G>T
NC_000002.12:g.151658091C>A
CM000664.2:g.151658091C>A
NC_000002.11:g.152514605C>A
CM000664.1:g.152514605C>A
NC_000002.10:g.152222851C>A
NG_009382.2:g.81397G>T
ENST00000397345.8:c.6076-1G>T
ENST00000427231.7:c.6076-1G>T
ENST00000172853.14:c.6076-1G>T
ENST00000397345.7:c.6076-1G>T
ENST00000409198.5:c.6076-1G>T
ENST00000427231.6:c.6076-1G>T
ENST00000603639.5:c.6076-1G>T
ENST00000604864.5:c.6076-1G>T
ENST00000618972.4:c.6076-1G>T
NM_001164507.1:c.6076-1G>T
NM_001164508.1:c.6076-1G>T
NM_001271208.1:c.6076-1G>T
NM_004543.4:c.6076-1G>T
NM_001271208.2:c.6076-1G>T
NM_004543.5:c.6076-1G>T
NM_001164507.2:c.6076-1G>T
More

Likely Pathogenic

Met criteria codes 3
PVS1_Strong PM2_Supporting PM5
Not Met criteria codes 3
BS1 BA1 PM3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Congenital Myopathies Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for NEB Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Congenital Myopathies VCEP
The c.6076-1G>T variant in NEB occurs within the canonical splice acceptor site -1 of intron 47. It is predicted to cause skipping of biologically-relevant-exon 48/182, resulting in an in-frame deletion (removes amino acids 2026-2061) that is predicted to escape nonsense mediated decay (PVS1_Strong). The highest population minor allele frequency in gnomAD 4.1.0 is 0.00002698 (2/74116) in the African American population which meets the threshold to apply PM2_Supporting (MAF≤0.0000559). An additional pathogenic variant was identified in multiple affected probands at the same canonical splice acceptor site (c.6076-2A>C) (Invitae, SCV001204195.4) (PM5). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal recessive nemaline myopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen Congenital Myopathies VCEP: PVS1_Strong, PM5, PM2_Supporting. (Congenital Myopathies VCEP specifications version 1; 8/7/2024)
Met criteria codes
PVS1_Strong
The c.6076-1G>T variant in NEB occurs within the canonical splice acceptor site -1 of intron 47. It is predicted to cause skipping of biologically-relevant-exon 48/182, resulting in an in-frame deletion (removes amino acids 2026-2061)
PM2_Supporting
The highest population minor allele frequency is 0.00002698 (2/74116) in the African American population (MAF meets PM2_P threshold)
PM5
An additional pathogenic variant was identified in multiple affected probands at the same canonical splice acceptor site, (c.6076-2A>C) (Invitae, SCV001204195.4)
Not Met criteria codes
BS1
The highest population minor allele frequency is 0.00002698 (2/74116) in the African American population
BA1
The highest population minor allele frequency is 0.00002698 (2/74116) in the African American population
PM3
Invitae identified this variant as heterozygous (no second NEB variant) in 2 unrelated adults undergoing carrier screening (and thus presumably clinically unaffected). An additional pathogenic variant was identified in multiple affected probands at the same canonical splice acceptor site, (c.6076-2A>C) (SCV001204195.4)
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.